Products

Online Inquiry

As a CRO specializing in cardiovascular disease research, Ace Therapeutics offers a range of inhibitors & activators to study and understand the mechanisms underlying various cardiovascular conditions. These compounds play a crucial role in drug discovery and the development of potential therapies.

Inhibitors & Activators

Arenobufagin 3-hemisuberate (CDIA-1518) Inquiry
Formula:
C32H44O9
CAS Number:
30219-16-0
Molecular Weight:
572.69

Guanfu base G (CDIA-1519) Inquiry
Formula:
C26H33NO7
CAS Number:
78969-72-9
Molecular Weight:
471.54

Guanfu base I (CDIA-1520) Inquiry
Formula:
C22H29NO5
CAS Number:
110225-59-7
Molecular Weight:
387.47

11α, 12α-Epoxy-3β, 23-dihydroxy-30-norolean-20 (29)-en-28 (CDIA-1521) Inquiry
Formula:
C29H42O5
CAS Number:
186140-36-3
Molecular Weight:
470.64

Leucylarginylproline (CDIA-1522) Inquiry
Formula:
C17H32N6O4
CAS Number:
133943-59-6
Molecular Weight:
384.47

Sauvagine (CDIA-1523) Inquiry
Formula:
C202H346N56O63S
CAS Number:
74434-59-6
Molecular Weight:
4599.31

PHM-27, (human) (CDIA-1524) Inquiry
Formula:
C135H214N34O40S
CAS Number:
87403-73-4
Molecular Weight:
2985.41

Saralasin (CDIA-1525) Inquiry
Formula:
C42H65N13O10
CAS Number:
34273-10-4
Molecular Weight:
912.05

Sarafotoxin S6a (CDIA-1526) Inquiry
Formula:
C105H156N28O34S5
CAS Number:
126738-34-9
Molecular Weight:
2514.85

Urotensin II (114-124), (human) (CDIA-1527) Inquiry
Formula:
C64H85N13O18S2
CAS Number:
251293-28-4
Molecular Weight:
1388.57

! For research use only. Not intended for any clinical use.